Skip to content
OpenCapital
Get started

InMed Pharmaceuticals INM Q4 2025 earnings

Reported February 11, 2026 · After market close

Revenue$1.1M
EPS-$0.51

Next report

Sep 23, 2026 (in 2 months)
EPS estimate-$94.44

Versus estimates

Revenue

Q1 2026$1.3MMiss by $658.6M
Q4 2025$1.1M
Q3 2025$1.1MQ2 2025$1.8MQ1 2025$1.8MQ4 2024$772.5M

Diluted EPS

Q1 2026-$0.69Beat by $93.75
Q4 2025-$0.51
Q3 2025-$0.44Q2 2025-$3.80Q1 2025-$1.94Q4 2024-$3.64

Ask the moment InMed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did InMed Pharmaceuticals report Q4 2025 earnings?
InMed Pharmaceuticals (INM) reported Q4 2025 earnings on February 11, 2026 after market close.
What were InMed Pharmaceuticals's Q4 2025 revenue and EPS?
InMed Pharmaceuticals reported revenue of $1.1M and eps of $-0.51 for Q4 2025.
How did InMed Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 99.9% from $772.5M a year earlier and eps grew 86.0% from $-3.64.
Where can I find InMed Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001062993-26-000819) and the 10-Q periodic report (0001213900-26-014996) directly on SEC EDGAR. The filing index links above go to sec.gov.